Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis

Philippe Montravers1, Guillaume Dufour2, Jean Guglielminotti3

  • 1Département d'Anesthésie Réanimation, Université Paris Diderot, APHP, CHU Bichat-Claude Bernard, 46, Rue Henri Huchard, Paris, 75018, France. philippe.montravers@bch.aphp.fr.

Abstract

Insights

Persistent peritonitis leads to more multidrug-resistant (MDR) strains with each reoperation. Timely source control, not antibiotics, is key to preventing MDR bacteria emergence in these critical cases.

Area of Science:

  • Intensive Care Medicine
  • Surgical Infections
  • Microbiology

Background:

  • Persistent peritonitis is a common, severe complication of secondary peritonitis.
  • It often necessitates repeated surgeries and antibiotic treatments, raising concerns about multidrug-resistant (MDR) strains.
  • The dynamics of MDR strain emergence in persistent peritonitis require further investigation.

Purpose of the Study:

  • To compare clinical, microbiological, and therapeutic data between patients with and without persistent peritonitis.
  • To analyze the emergence and dynamics of MDR strains in patients undergoing reoperations for persistent peritonitis.
  • To identify risk factors associated with the emergence of MDR strains.

Main Methods:

  • A comparative study of ICU patients with postoperative peritonitis, divided into groups with and without reoperation.
  • Analysis of clinical, microbiological, and therapeutic data from index surgery and subsequent reoperations.
  • Multivariate analysis to assess risk factors for MDR strain emergence.

Main Results:

  • Persistent peritonitis cases showed higher initial severity and fungal isolates.
  • Septic shock was the primary clinical manifestation.
  • MDR strains significantly increased with each reoperation, from 41% at index surgery to 76% by the third reoperation.
  • Time to reoperation was the sole identified risk factor for MDR emergence.

Conclusions:

  • Initial severity, Candida presence, and inadequate source control are key risk factors for persistent peritonitis.
  • MDR bacteria emergence is frequent and escalates with the number of reoperations.
  • Effective source control, rather than antibiotic regimens, is critical in managing MDR strain emergence.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.8K
Microbiota of the Stomach and Small Intestine01:27

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...
60
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
49
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
101
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
49
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
89